497 related articles for article (PubMed ID: 9564642)
1. Clomiphene citrate-resistant polycystic ovary syndrome. Preventing multifollicular development.
Ergür AR; Yergök YZ; Ertekin A; Küçük T; Müngen E; Tütüncü L
J Reprod Med; 1998 Mar; 43(3):185-90. PubMed ID: 9564642
[TBL] [Abstract][Full Text] [Related]
2. Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH.
Tan SL; Farhi J; Homburg R; Jacobs HS
Obstet Gynecol; 1996 Aug; 88(2):221-6. PubMed ID: 8692506
[TBL] [Abstract][Full Text] [Related]
3. [Treatment options of clomiphene-resistant polycystic ovary syndrome related infertility].
Liang X; Zhuang G; Zhou C
Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):591-3. PubMed ID: 11372407
[TBL] [Abstract][Full Text] [Related]
4. Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study.
Xi W; Liu S; Mao H; Yang Y; Xue X; Lu X
Drug Des Devel Ther; 2015; 9():6001-8. PubMed ID: 26648691
[TBL] [Abstract][Full Text] [Related]
5. The laparoscopic ovarian electrocautery versus gonadotropin therapy in infertile women with clomiphene citrate-resistant polycystic ovary syndrome; a randomized controlled trial.
Mehrabian F; Eessaei F
J Pak Med Assoc; 2012 Mar; 62(3 Suppl 2):S42-4. PubMed ID: 22768457
[TBL] [Abstract][Full Text] [Related]
6. The cycle characteristics of clomiphene with clomiphene and menotropins in polycystic ovary syndrome and non polycystic ovary syndrome infertile patients.
Ghasemi M; Ashraf H; Koushyar H; Mousavifar N
Minerva Ginecol; 2013 Jun; 65(3):311-7. PubMed ID: 23689174
[TBL] [Abstract][Full Text] [Related]
7. [Chronic low dose follicle stimulating hormone step-up regimen in the treatment of polycystic ovary syndrome related anovulatory infertility with clomiphene resistance].
Chen W; Zhang Y; Dai Q
Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):588-90. PubMed ID: 11372406
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a new surgical approach for the treatment of clomiphene citrate-resistant infertility in polycystic ovary syndrome: laparoscopic ovarian multi-needle intervention.
Kaya H; Sezik M; Ozkaya O
J Minim Invasive Gynecol; 2005; 12(4):355-8. PubMed ID: 16036198
[TBL] [Abstract][Full Text] [Related]
9. Ovulatory disorders in women with polycystic ovary syndrome.
Franks S; Adams J; Mason H; Polson D
Clin Obstet Gynaecol; 1985 Sep; 12(3):605-32. PubMed ID: 3933879
[TBL] [Abstract][Full Text] [Related]
10. Induction of ovulation in the patient with polycystic ovarian disease.
Blankstein J; Quigley MM
Endocrinol Metab Clin North Am; 1988 Dec; 17(4):733-49. PubMed ID: 3143566
[TBL] [Abstract][Full Text] [Related]
11. [Continuous pulsatile subcutaneous gonadotropin stimulation in polycystic ovary syndrome: a therapeutic alternative].
Steck T; Würfel W; Witteler M; Albert P
Geburtshilfe Frauenheilkd; 1991 May; 51(5):373-8. PubMed ID: 1907938
[TBL] [Abstract][Full Text] [Related]
12. Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients.
Hosseini MA; Aleyasin A; Saeedi H; Mahdavi A
J Obstet Gynaecol Res; 2010 Jun; 36(3):605-10. PubMed ID: 20598044
[TBL] [Abstract][Full Text] [Related]
13. [Optimal Ovulation Induction in Polycystic Ovary Syndrome Resistant to Clomiphene Citrate or Letrozole.].
Chen Y; Zhang D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):874-877. PubMed ID: 28598116
[TBL] [Abstract][Full Text] [Related]
14. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
Parsanezhad ME; Alborzi S; Jahromi BN
Int J Fertil Womens Med; 2002; 47(6):272-7. PubMed ID: 12570169
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of therapeutic outcomes of polycystic ovary syndrome patients with hyperprolactinemia].
Shi YH; Sheng Y; Chen ZJ; Yan JH; Gao Q; Liu H; Ma ZX
Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):251-3. PubMed ID: 18843962
[TBL] [Abstract][Full Text] [Related]
17. Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction.
Blumenfeld Z; Lang N; Amit A; Kahana L; Yoffe N
Fertil Steril; 1994 Sep; 62(3):456-60. PubMed ID: 8062938
[TBL] [Abstract][Full Text] [Related]
18. Ovulation induction with gonadotropins in women with polycystic ovary disease.
Kupferminc MJ; Lessing JB; Peyser MR
J Reprod Med; 1991 Jan; 36(1):61-4. PubMed ID: 1901089
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of total testosterone for pregnancy during treatment in patients with clomiphene-citrate-resistant polycystic ovary syndrome: a pilot study.
Li C; Cheng J; Wang J; Xue Y; Huang Z; Zhang S; Lv J
Arch Gynecol Obstet; 2011 Sep; 284(3):757-64. PubMed ID: 21614496
[TBL] [Abstract][Full Text] [Related]
20. Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients.
Tehraninejad ES; Nasiri R; Rashidi B; Haghollahi F; Ataie M
Arch Gynecol Obstet; 2010 Sep; 282(3):319-25. PubMed ID: 20379731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
